{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05255",
      "entity_text" : "EFTFs",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0309" ],
      "Organ" : [ "uberon:UBERON:0000105" ],
      "Species" : [ "taxonomy:7955" ]
    }
  },
  "verbose_text" : "At stage 17, increased expression of EFTFs (Rx1 Pax6, Otx2; XREF_FIG A-E) and hyper-proliferation characterized MD3 morphants (XREF_FIG A, C); followed by increased apoptotic activity (XREF_FIG B, D) and a reduced eye field (XREF_FIG B-F) at stage 30.",
  "reading_complete" : "2020-08-04T13:25:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:24:01Z",
  "trigger" : "expression",
  "evidence" : [ "expression of EFTFs" ],
  "pmc_id" : "5155527",
  "score" : 0
}